Fresenius SE & Co KGaA (FRA:FRE) Receives “Neutral” Rating from UBS Group

Share on StockTwits

UBS Group reiterated their neutral rating on shares of Fresenius SE & Co KGaA (FRA:FRE) in a report released on Monday, Borsen Zeitung reports.

Other research analysts have also recently issued research reports about the company. DZ Bank restated a buy rating on shares of Fresenius SE & Co KGaA in a research note on Monday. Independent Research set a €54.00 ($62.79) price target on Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Monday, February 24th. Barclays restated a neutral rating on shares of Fresenius SE & Co KGaA in a research note on Tuesday, March 3rd. Sanford C. Bernstein set a €42.90 ($49.88) price target on Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Tuesday, March 10th. Finally, Warburg Research set a €63.00 ($73.26) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a research note on Thursday, February 20th. Seven research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Fresenius SE & Co KGaA presently has a consensus rating of Buy and a consensus target price of €54.83 ($63.75).

Shares of FRA:FRE opened at €34.47 ($40.08) on Monday. The stock has a fifty day simple moving average of €41.16 and a two-hundred day simple moving average of €45.61. Fresenius SE & Co KGaA has a 12-month low of €60.16 ($69.95) and a 12-month high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

See Also: Dividend Reinvestment Plan (DRIP)

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Secure Trust Bank  Rating Reiterated by Peel Hunt
Secure Trust Bank Rating Reiterated by Peel Hunt
Sumo Group  Stock Rating Upgraded by Jefferies Financial Group
Sumo Group Stock Rating Upgraded by Jefferies Financial Group
United Utilities Group  Price Target Cut to GBX 1,070
United Utilities Group Price Target Cut to GBX 1,070
Vodafone Group  PT Set at GBX 200 by UBS Group
Vodafone Group PT Set at GBX 200 by UBS Group
Brenntag  PT Set at €53.00 by Goldman Sachs Group
Brenntag PT Set at €53.00 by Goldman Sachs Group
freenet  PT Set at €14.00 by Goldman Sachs Group
freenet PT Set at €14.00 by Goldman Sachs Group


 
© 2006-2020 Zolmax.